Prof. Giovanni Staurenghi, chairman of the University Eye Clinic, Department of Biomedical and Clinical Sciences at the University of Milan’s Luigi Sacco Hospital, Italy, discusses his presentation from this year's AAO, including findings from the HARBOR study of macular atrophy in AMD patients treated with ranibizumab.
Ted Leng, MD, MS, Byers Eye Institute at Stanford, and medical advisor for Verana Health, talks about data insights for retinal surgeons. Steven D. Schwartz, MD, Stein Eye Institute, UCLA, highlights his AAO presentation, “New Insight into Real-World U.S. Injection Data."
During Day 1 of AAO 2020, Carl Awh, MD, discusses the Micro-Vacuum Pick, a device for peeling internal limiting membranes that's providing vitreoretinal surgeons an alternative to forceps during surgeries.
At AAO 2020, Fernando Arevalo, MD, PhD, details the use of anti-VEGF therapy for the treatment of retinal arteriolar macroaneurysms that are near the fovea.
Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.
Prof. Marie-José Tassignon, past chief and chair, Department of Ophthalmology, Antwerp University and University Hospital Antwerp, Belgium, expands on her upcoming AAO presentation by providing an overview of her novel technique in performing a risk-free posterior capsulorhexis.
Anne L. Coleman, MD, president of the American Academy of Ophthalmology, offers a preview of its virtual 2020 annual meeting. The AAO is rising to meet the challenges of staging a large-scale event in a virtual setting.
American Academy of Ophthalmology (AAO) President Anne L. Coleman, MD, PhD, offers a preview of what attendees can look forward to from the academy's virtual annual meeting — kicking off Nov. 13-15.
Anne L. Coleman, MD, PhD, shares advice for others who are interested in pursuing a leadership role based on 5 dimensions of centered leadership.
The American Academy of Ophthalmology (AAO) is taking its annual meeting virtual amid the COVID-19 pandemic.
Chuck Hess provides a company update at the OIS@AAO meeting in Chicago, Oct. 2018.
Erin D. Stahl, MD, discusses why it's important to diagnose and treat children with keratoconus at the earliest signs of development for successful outcomes during the AAO 2018 meeting in Chicago.
Elad Kedar, CEO of Orasis Pharmaceuticals, provides a company update at OIS@AAO 2018 in Chicago.
Joint event to feature plenty of symposia, practice management programs, product innovations
The American Academy of Ophthalmology (AAO) has officially launched the Intelligent Research in Sight (IRIS) Registry, the United States’ first comprehensive eye disease and condition registry.
.png "Optometry Times"){kind=logo}
